Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1.
Tahira BalochVanessa M López-OzunaQiong WangEmad MatanisRoy KessousLiron KoganAmber YasmeenWalter H GotliebPublished in: BMC cancer (2019)
Pre-treatment with PARPi followed by standard chemotherapy in vitro is more efficient in growth inhibition and induction of apoptosis compared to the administration of standard chemotherapy followed by PARPi.